WO2010063995A3 - Telmisartan en formulations diurétiques - Google Patents

Telmisartan en formulations diurétiques Download PDF

Info

Publication number
WO2010063995A3
WO2010063995A3 PCT/GB2009/002791 GB2009002791W WO2010063995A3 WO 2010063995 A3 WO2010063995 A3 WO 2010063995A3 GB 2009002791 W GB2009002791 W GB 2009002791W WO 2010063995 A3 WO2010063995 A3 WO 2010063995A3
Authority
WO
WIPO (PCT)
Prior art keywords
diuretic
telmisartan
formulations
mantle
formulated
Prior art date
Application number
PCT/GB2009/002791
Other languages
English (en)
Other versions
WO2010063995A2 (fr
Inventor
Peter Henry Robert Persicaner
Rahul Sareen
Original Assignee
Arrow International Limited
Tabatznik, Anthony, S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arrow International Limited, Tabatznik, Anthony, S. filed Critical Arrow International Limited
Publication of WO2010063995A2 publication Critical patent/WO2010063995A2/fr
Publication of WO2010063995A3 publication Critical patent/WO2010063995A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un comprimé enrobé, comprenant un cœur de telmisartan entouré d'un enrobage contenant un diurétique.
PCT/GB2009/002791 2008-12-04 2009-12-01 Telmisartan en formulations diurétiques WO2010063995A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0822170.7A GB0822170D0 (en) 2008-12-04 2008-12-04 Telmisartan with diuretic formulations
GB0822170.7 2008-12-04
GB0913884.3 2009-08-10
GBGB0913884.3A GB0913884D0 (en) 2008-12-04 2009-08-10 Telmisartan with diuretic formulations

Publications (2)

Publication Number Publication Date
WO2010063995A2 WO2010063995A2 (fr) 2010-06-10
WO2010063995A3 true WO2010063995A3 (fr) 2010-11-25

Family

ID=40289506

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2009/002791 WO2010063995A2 (fr) 2008-12-04 2009-12-01 Telmisartan en formulations diurétiques

Country Status (2)

Country Link
GB (2) GB0822170D0 (fr)
WO (1) WO2010063995A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2612658A1 (fr) * 2012-01-05 2013-07-10 Laboratorios Lesvi, S.L. Compositions pharmaceutiques d'acide 4'-[(1,4'diméthyl-2'-propyl[2,6'-BI-1H-benzimidazol]-1'-YL)méthyl]-[1,1'-biphényl]-2-carboxylique et IS 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxyde

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006063737A1 (fr) * 2004-12-17 2006-06-22 Boehringer Ingelheim International Gmbh Therapie combinatoire impliquant le telmisartan et l'hydrochlorothiazide
WO2007144175A2 (fr) * 2006-06-16 2007-12-21 Lek Pharmaceuticals D.D. Composition pharmaceutique
CN101134032A (zh) * 2007-09-24 2008-03-05 湖北丝宝药业有限公司 一种治疗高血压的复方制剂及其制备方法
WO2009058950A2 (fr) * 2007-10-30 2009-05-07 Dr. Reddy's Laboratories Ltd. Formulations pharmaceutiques comprenant du telmisartan et de l'hydrochlorotiazide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006063737A1 (fr) * 2004-12-17 2006-06-22 Boehringer Ingelheim International Gmbh Therapie combinatoire impliquant le telmisartan et l'hydrochlorothiazide
WO2007144175A2 (fr) * 2006-06-16 2007-12-21 Lek Pharmaceuticals D.D. Composition pharmaceutique
CN101134032A (zh) * 2007-09-24 2008-03-05 湖北丝宝药业有限公司 一种治疗高血压的复方制剂及其制备方法
WO2009058950A2 (fr) * 2007-10-30 2009-05-07 Dr. Reddy's Laboratories Ltd. Formulations pharmaceutiques comprenant du telmisartan et de l'hydrochlorotiazide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 10 April 2008 (2008-04-10), XP002602665, retrieved from stn Database accession no. 148:363419 *

Also Published As

Publication number Publication date
GB0822170D0 (en) 2009-01-14
GB0913884D0 (en) 2009-09-16
WO2010063995A2 (fr) 2010-06-10

Similar Documents

Publication Publication Date Title
AP2011005856A0 (en) Saccharifying biomass.
EP2043972B8 (fr) Production de biocarburant au moyen de catalyseurs composites
AP2010005383A0 (en) Densified fuel pellets.
AU2009200484B2 (en) Densified fuel pellets
AP2011005548A0 (en) Heterogeneous hydrogen-catalyst reactor.
EP2595160A4 (fr) Ensemble noyau pour transmission d'énergie sans fil et dispositif d'alimentation électrique pour transmission d'énergie sans fil le comprenant, et procédé de fabrication d'ensemble noyau pour transmission d'énergie sans fil
WO2010141885A3 (fr) Localisation à la demande
JP2012065100A5 (fr)
MX301000B (es) Produccion de etanol en microorganismos.
JP2010244935A5 (fr)
IT1396927B1 (it) Turbina ad elevate prestazioni, particolarmente a potenza specifica incrementata.
EP2495355A4 (fr) Moule, procédé de fabrication d'un moule, et film anti-réfléchissant
BRPI0816865A2 (pt) Monitoramento de pressão anular durante fraturamento hidráulico.
WO2010048389A3 (fr) Pastilles pharmaceutiques comportant de l’amidon modifié et leurs applications thérapeutiques
IT1392575B1 (it) Amplificatore con combinatore di potenza differenziale, a trasformatore attivo distribuito
WO2010112452A9 (fr) Bisimides de pérylène oligocondensés
FR2883449B1 (fr) Plantoir hydromecanique a double fonction.
WO2008148396A3 (fr) Tampon
MX2009006479A (es) Derivados de hemicelulosa y estructuras que los emplean.
USD644262S1 (en) Type font
WO2010063995A3 (fr) Telmisartan en formulations diurétiques
FR2920140B1 (fr) Nacelle de turboreacteur, destinee a equiper un aeronef
IT1397271B1 (it) Pressa a doppio nastro.
WO2009054483A1 (fr) Medicament contenant de la salusine-β
WO2011159740A3 (fr) Méthodes de fabrication de métabolites de tétranor-prostaglandine d, j, e, a et f

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09763998

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09763998

Country of ref document: EP

Kind code of ref document: A2